|
|
Line 39: |
Line 39: |
| ===2021: [https://www.ingentaconnect.com/contentone/png/ajhb/2021/00000045/00000003/art00004#expand/collapse Switching away from Cigarettes across 12 Months among Adult Smokers Purchasing the JUUL System]=== | | ===2021: [https://www.ingentaconnect.com/contentone/png/ajhb/2021/00000045/00000003/art00004#expand/collapse Switching away from Cigarettes across 12 Months among Adult Smokers Purchasing the JUUL System]=== |
| *Rates of switching with JUUL increased over time. Over 50% of respondents reported complete switching away from cigarettes 12 months following purchase. Greater use of and dependence on JUUL predicted switching. | | *Rates of switching with JUUL increased over time. Over 50% of respondents reported complete switching away from cigarettes 12 months following purchase. Greater use of and dependence on JUUL predicted switching. |
|
| |
| ===2021: [https://academic.oup.com/ntr/advance-article/doi/10.1093/ntr/ntab148/6322566 Reappraising Choice in Addiction: Novel Conceptualizations and Treatments for Tobacco Use Disorder]===
| |
| *Given the advent of novel, alternative tobacco products, Tobacco Use Disorder must be conceptualized within a contemporary framework that includes harm reduction and alternative outcomes.
| |
| *[https://academic.oup.com/ntr/advance-article-pdf/doi/10.1093/ntr/ntab148/39068104/ntab148.pdf PDF Version]
| |
|
| |
|
| ===2021: [https://pubmed.ncbi.nlm.nih.gov/34002223/ Differences in Switching Away From Smoking Among Adult Smokers Using JUUL Products in Regions With Different Maximum Nicotine Concentrations: North America and the United Kingdom]=== | | ===2021: [https://pubmed.ncbi.nlm.nih.gov/34002223/ Differences in Switching Away From Smoking Among Adult Smokers Using JUUL Products in Regions With Different Maximum Nicotine Concentrations: North America and the United Kingdom]=== |
Line 49: |
Line 45: |
| ===2020: [https://pubmed.ncbi.nlm.nih.gov/32877429/ Role of e-cigarettes and pharmacotherapy during attempts to quit cigarette smoking: The PATH Study 2013-16]=== | | ===2020: [https://pubmed.ncbi.nlm.nih.gov/32877429/ Role of e-cigarettes and pharmacotherapy during attempts to quit cigarette smoking: The PATH Study 2013-16]=== |
| *Among US daily smokers who quit cigarettes in 2014-15, use of e-cigarettes in that attempt compared to approved cessation aids or no products showed similar abstinence rates 1-2 years later. | | *Among US daily smokers who quit cigarettes in 2014-15, use of e-cigarettes in that attempt compared to approved cessation aids or no products showed similar abstinence rates 1-2 years later. |
| | |
| | ===2019: [https://onlinelibrary.wiley.com/doi/full/10.1111/add.14851 Association of prevalence of electronic cigarette use with smoking cessation and cigarette consumption in England: a time–series analysis between 2007 and 2017]=== |
| | *The increase in prevalence of e‐cigarette use by smokers in England has been positively associated with an increase in success rates of quit attempts and overall quit rates |
| | *[https://onlinelibrary.wiley.com/doi/epdf/10.1111/add.14851 PDF Version] |
| <br> | | <br> |
|
| |
|